Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Benign prostatic hyperplasia(BPH) is a common disease in urology among old men. If BPH
 symptom cannot be controlled by drugs, then transurethral resection of the prostate (TURP),
 is recommended. Although the procedure is quit safe, these old men often take anticoagulants
 and antiplatelets to control cardiovascular diseases, which arose some concerns for their
 bleeding risk. The management of anticoagulation in patients undergoing surgical procedures
 is challenging because interrupting anticoagulation increases the risk of thrombotic events.
 At the same time, surgery and invasive procedures have associated bleeding risks that are
 increased by the anticoagulant administration. Now, the recommendation about anticoagulants
 and antiplatelets discontinuation had no concrete evidence, especially in TURP. Furthermore,
 there is no relative studies done in Taiwan population, which calls for further
 investigation.
Inclusion Criteria:

 -  Admitted to National Cheng Kung University Hospital Urology during the study

 -  Older than 20 years old

 -  Agree to participate this study

 -  Receiving transurethral resection of the prostate for benign prostatic hyperplasia or
 prostate cancer

 Exclusion Criteria:

 -  Poor expression ability and without close care givers to answer questions